Importantly, however, it is likely the effects of INK4/ARF expression on the development of atherosclerosis do not result from their expression in PBTL, but rather, observations in PBTL may serve as a surrogate for INK4/ARF expression in other tissues. This evidence concerns the gene CDKN2A and atherosclerosis.